<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Parvez S</submitter><funding>American Heart Association</funding><funding>NHLBI NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>1146-1151</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9083377</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>373(6559)</volume><pubmed_abstract>CRISPR-Cas9 can be scaled up for large-scale screens in cultured cells, but CRISPR screens in animals have been challenging because generating, validating, and keeping track of large numbers of mutant animals is prohibitive. Here, we introduce Multiplexed Intermixed CRISPR Droplets (MIC-Drop), a platform combining droplet microfluidics, single-needle en masse CRISPR ribonucleoprotein injections, and DNA barcoding to enable large-scale functional genetic screens in zebrafish. The platform can efficiently identify genes responsible for morphological or behavioral phenotypes. In one application, we showed that MIC-Drop could identify small-molecule targets. Furthermore, in a MIC-Drop screen of 188 poorly characterized genes, we discovered several genes important for cardiac development and fu</pubmed_abstract><journal>Science (New York, N.Y.)</journal><pubmed_title>MIC-Drop: A platform for large-scale in vivo CRISPR screens.</pubmed_title><pmcid>PMC9083377</pmcid><funding_grant_id>UM1 HL098160</funding_grant_id><funding_grant_id>U54 NS112107</funding_grant_id><funding_grant_id>OD R24OD017870</funding_grant_id><funding_grant_id>U01 HL098160</funding_grant_id><funding_grant_id>827636</funding_grant_id><funding_grant_id>NINDS U54-NS079201</funding_grant_id><funding_grant_id>R01 GM134069</funding_grant_id><funding_grant_id>R24 OD017870</funding_grant_id><funding_grant_id>5R01GM134069-02</funding_grant_id><pubmed_authors>Herdman C</pubmed_authors><pubmed_authors>Peterson RT</pubmed_authors><pubmed_authors>Chakraborti K</pubmed_authors><pubmed_authors>MacRae CA</pubmed_authors><pubmed_authors>Yost HJ</pubmed_authors><pubmed_authors>Yeh JJ</pubmed_authors><pubmed_authors>Beerens M</pubmed_authors><pubmed_authors>Parvez S</pubmed_authors><pubmed_authors>Harmer ZP</pubmed_authors></additional><is_claimable>false</is_claimable><name>MIC-Drop: A platform for large-scale in vivo CRISPR screens.</name><description>CRISPR-Cas9 can be scaled up for large-scale screens in cultured cells, but CRISPR screens in animals have been challenging because generating, validating, and keeping track of large numbers of mutant animals is prohibitive. Here, we introduce Multiplexed Intermixed CRISPR Droplets (MIC-Drop), a platform combining droplet microfluidics, single-needle en masse CRISPR ribonucleoprotein injections, and DNA barcoding to enable large-scale functional genetic screens in zebrafish. The platform can efficiently identify genes responsible for morphological or behavioral phenotypes. In one application, we showed that MIC-Drop could identify small-molecule targets. Furthermore, in a MIC-Drop screen of 188 poorly characterized genes, we discovered several genes important for cardiac development and fu</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-04T20:22:01.209Z</modification><creation>2025-04-04T20:22:01.209Z</creation></dates><accession>S-EPMC9083377</accession><cross_references><pubmed>34413171</pubmed><doi>10.1126/science.abi8870</doi></cross_references></HashMap>